The airplane maker reportedly faces more delays with
Investors were disappointed by results from a key study on a potential cancer treatment.
The drug developer gave investors an encouraging update on a developing treatment for a genetic disorder.
Private equity firm Thoma Bravo is buying the manufacturing software maker for about
The healthcare facility owner and manager is buying
The online crafts marketplace is buying
The cruise line operator plans to raise up to
The biotechnology company reported encouraging results from a study on a potential Parkinson’s disease treatment.
Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source